Professor Marc Mansour is an honorary consultant haematologist at University College London Hospital and Great Ormond Street Children's Charity professor of haematolgy at GOS ICH/UCL Cancer Institute. He undertook his medical degree at the University of Edinburgh, medical training at King's College London and UCLH, followed by an MRC clinical research training PhDship in the laboratory of Professors David Linch and Rosemary Gale at UCL, where he studied notch signalling in acute leukaemia. He was funded by the Kay Kendell Leukemia Research Fund to undertake a travelling fellowship at Harvard Medical School and Dana-Farber Cancer Institute in Boston, USA. He was awarded the HMS Claudia Adams Barr Innovative Research award, and was a Harvard Medical School faculty member from 2012-2014. He was funded through a Bennett senior fellowship (Blood Cancer UK) to establish his own research lab at the UCL Cancer Institute in 2014. His research has focused on two aggressive haematological malignancies - T-cell acute lymphoblastic leukaemia (T-ALL) and acute myeloid leukaemia (AML). He has published extensively on the biology of acute leukaemia, authoring papers in Science, Nature, Nature Cell Biology, JCI, ELife, JCO and J Ex Med. His clinical interest is in ALL, AML and myelodysplasia (MDS).
-State-of-the-Art lecture M. Mansour (UK) -The role of immune therapies in treatment of ALL patients E. Ünal İnce (Türkiye) -The role of immunotherapy in R/R ALL B. Todorova (Slovenia) -Chimeric Antigen Receptor T-Cell Therapy in Adult B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant? P. Tsirigotis (Greece) -Management of side effects of novel drugs in ALL B. Viktor (Croatia) -Panel discussion /All speakers